Decreasing Adverse Events in Pediatric Patients With End-Stage Renal Disease

Insights

Pediatric patients with end-stage renal disease (ESRD) living far from specialized care face increased adverse events. An emergency room dialysis card improved communication and aimed to reduce these events in children with ESRD.

Area of Science:

  • Pediatric Nephrology
  • Patient Safety
  • Healthcare Communication

Background:

  • Children with end-stage renal disease (ESRD) residing far from specialized pediatric facilities face heightened risks of adverse events.
  • A pediatric dialysis unit serves 27 chronic ESRD patients, with 19 living over an hour away.
  • Past adverse events at external facilities included sepsis, infections, and compromised kidney function due to nephrotoxic drugs.

Purpose of the Study:

  • To describe an improvement initiative focused on reducing adverse events in pediatric ESRD patients needing urgent or emergent care.
  • To evaluate the effectiveness of an emergency room dialysis card as a communication tool.

Main Methods:

  • Implementation of an emergency room dialysis card system.
  • Focus on improving communication among patients, families, and healthcare providers for pediatric ESRD patients requiring urgent care.

Main Results:

  • Adverse events, including sepsis and infections, have occurred in patients treated at other hospitals.
  • The improvement effort specifically targeted reducing these adverse events through enhanced communication.

Conclusions:

  • Effective communication tools are crucial for managing pediatric ESRD patients, especially those requiring urgent care.
  • The emergency room dialysis card initiative aims to mitigate risks associated with distance and access to specialized pediatric renal services.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
284
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K